Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Evogene (EVGN) EBT Margin (2016 - 2025)

Historic EBT Margin for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to 874.36%.

  • Evogene's EBT Margin fell 4866000.0% to 874.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 157.21%, marking a year-over-year increase of 1589000.0%. This contributed to the annual value of 265.52% for FY2024, which is 1952400.0% up from last year.
  • As of Q3 2025, Evogene's EBT Margin stood at 874.36%, which was down 4866000.0% from 399.1% recorded in Q2 2025.
  • Evogene's 5-year EBT Margin high stood at 61.45% for Q4 2024, and its period low was 5519.87% during Q3 2021.
  • For the 5-year period, Evogene's EBT Margin averaged around 1613.1%, with its median value being 1096.1% (2023).
  • Data for Evogene's EBT Margin shows a peak YoY increase of 74749300bps (in 2021) and a maximum YoY decrease of -38075300bps (in 2021) over the last 5 years.
  • Over the past 5 years, Evogene's EBT Margin (Quarter) stood at 2601.29% in 2021, then soared by 78bps to 572.12% in 2022, then crashed by -122bps to 1270.07% in 2023, then surged by 105bps to 61.45% in 2024, then crashed by -1523bps to 874.36% in 2025.
  • Its EBT Margin was 874.36% in Q3 2025, compared to 399.1% in Q2 2025 and 122.3% in Q1 2025.